Combination therapy with lansoprazole and cholecalciferol is associated with a slower decline in residual beta-cell function and lower insulin requirements in children with recent onset type 1 diabetes: results of a pilot study.

Published in: Einstein (Sao Paulo, Brazil) (2022)

(www.ctri.nic.in) under number REF/2021/03/041415 N.

Keyphrases